NCT01618656View on ClinicalTrials.gov

Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 12, 2012

Primary Completion Date

March 11, 2016

Study Completion Date

March 11, 2016

Conditions
Cannabis Dependence
Interventions
DRUG

PF-04457845

Study medication will be administered at 4mg by mouth daily for four weeks.

DRUG

Placebo

Sugar pill

Trial Locations (1)

06511

Yale University School of Medicine, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT01618656 - Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal | Biotech Hunter | Biotech Hunter